Discovery of lipid profiles in plasma‐derived extracellular vesicles as biomarkers for breast cancer diagnosis
Cancer Science · 2023-10 · 114 (10) · 4020-4031
DOI: 10.1111/cas.15935 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 22.08.2023. Verfasst von Lin Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Extracellular Vesicles, Biomarkers, Tumor, Breast Neoplasms, Lipids. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: China Scholarship Council, JST FOREST Program, Kyowa Kirin.
Abstract (Originalsprache)
Lipids are a major component of extracellular vesicles; however, their significance in tumorigenesis and progression has not been well elucidated. As we previously found that lipid profiles drastically changed in breast tumors upon progression, we hypothesized that lipid profiles of plasma‐derived extracellular vesicles could be utilized as breast cancer biomarkers. Here, we adopted modified sucrose cushion ultracentrifugation to isolate plasma‐derived extracellular vesicles from breast cancer ( n = 105), benign ( n = 11), and healthy individuals ( n = 43) in two independent cohorts ( n = 126 and n = 33) and conducted targeted lipidomic analysis. We established a breast cancer diagnostic model comprising three lipids that showed favorable performance with the area under the receiver operating characteristic curve of 0.759, 0.743, and 0.804 in the training, internal validation, and external test sets, respectively. Moreover, we identified several lipids that could effectively discriminate breast cancer progression and subtypes: phosphatidylethanolamines and phosphatidylserines were relatively higher in Stage III, whereas phosphatidylcholines and sphingomyelins were higher in Stage IV; phosphatidylcholines and ceramides were correspondingly concentrated in HER2‐positive patients, while lysophosphatidylcholines and polyunsaturated triglycerides were concentrated in the triple‐negative breast cancer subtype. Lipid profiling of plasma‐derived extracellular vesicles is a non‐invasive and promising approach for diagnosing, staging, and subtyping breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Institute of Medical Science, Tokyo Medical University, Tokyo, Japan.
- Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Life Science Research Center, Technology Research Laboratory, Shimadzu Corporation, Kyoto, Japan.
- Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
ORCID-Profile: Lin Liu, Wei Li, Masashi Takeda, Masakazu Toi
Förderung
- China Scholarship Council
- JST FOREST Program
- Kyowa Kirin
- Ministry of Education, Culture, Sports, Science and Technology KAKENHI
- Nippon Kayaku
- Shimadzu
- Kyowa Hakko Kirin
Zitieren
APA
Liu, L., Kawashima, M., Sugimoto, M., Sonomura, K., Pu, F., Li, W., Takeda, M., Goto, T., Kawaguchi, K., Sato, T. A., & Toi, M. (2023). Discovery of lipid profiles in plasma‐derived extracellular vesicles as biomarkers for breast cancer diagnosis. Cancer Science, 114(10), 4020-4031. https://doi.org/10.1111/cas.15935
Vancouver
Liu L, Kawashima M, Sugimoto M, Sonomura K, Pu F, Li W, et al. Discovery of lipid profiles in plasma‐derived extracellular vesicles as biomarkers for breast cancer diagnosis. Cancer Science. 2023;114(10):4020-4031. doi:10.1111/cas.15935
BibTeX
@article{Liu2023,
author = {Liu, Lin and Kawashima, Masahiro and Sugimoto, Masahiro and Sonomura, Kazuhiro and Pu, Fengling and Li, Wei and Takeda, Masashi and Goto, Takayuki and Kawaguchi, Kosuke and Sato, Taka-Aki and Toi, Masakazu},
title = {Discovery of lipid profiles in plasma‐derived extracellular vesicles as biomarkers for breast cancer diagnosis},
journal = {Cancer Science},
year = {2023},
volume = {114},
number = {10},
pages = {4020--4031},
doi = {10.1111/cas.15935}
}
EUVIMED